Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Deferred Taxes (2022 - 2025)

Historic Deferred Taxes for GeneDx Holdings (WGS) over the last 4 years, with Q3 2025 value amounting to $246000.0.

  • GeneDx Holdings' Deferred Taxes rose 62340.43% to $246000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $424000.0, marking a year-over-year increase of 15808.22%. This contributed to the annual value of -$343000.0 for FY2024, which is 6295.9% up from last year.
  • Latest data reveals that GeneDx Holdings reported Deferred Taxes of $246000.0 as of Q3 2025, which was up 62340.43% from -$245000.0 recorded in Q2 2025.
  • GeneDx Holdings' Deferred Taxes' 5-year high stood at $447000.0 during Q1 2025, with a 5-year trough of -$49.1 million in Q2 2022.
  • For the 4-year period, GeneDx Holdings' Deferred Taxes averaged around -$3.6 million, with its median value being -$123000.0 (2022).
  • Its Deferred Taxes has fluctuated over the past 5 years, first crashed by 89038.46% in 2023, then skyrocketed by 64512.2% in 2025.
  • Over the past 4 years, GeneDx Holdings' Deferred Taxes (Quarter) stood at $52000.0 in 2022, then crashed by 890.38% to -$411000.0 in 2023, then skyrocketed by 94.16% to -$24000.0 in 2024, then surged by 1125.0% to $246000.0 in 2025.
  • Its last three reported values are $246000.0 in Q3 2025, -$245000.0 for Q2 2025, and $447000.0 during Q1 2025.